SCHEMBL443557

SCHEMBL443557

O=C(O)c1c[c]ccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
TP53 P04637 1/20 0.47
TSHR P16473 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CASP1 P29466 1/20 0.42
KDM4E B2RXH2 5/20 0.40
TDP1 Q9NUW8 3/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
LMNA P02545 2/20 0.39
ALOX15 P16050 1/20 0.37
CYP1A2 P05177 1/20 0.37
CTSB P07858 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
AKR1C2 P52895 2/20 0.36
AKR1C1 Q04828 2/20 0.36
CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL750508 0.83 ALDH1A1 (0.50) ALDH1A1TP53TSHRSMN1; SMN2CASP1
SCHEMBL443893 0.81 CES2 (0.35) ALDH1A1TP53SMN1; SMN2POLBLMNA
SCHEMBL4806709 0.81 KMT2A (0.41) ALDH1A1TSHRKDM4EMAPTPOLB
SCHEMBL490677 0.79 ALDH1A1 (0.48) ALDH1A1TP53TSHRSMN1; SMN2KDM4E
SCHEMBL4323616 0.76 ALDH1A1 (0.50) ALDH1A1TP53TSHRSMN1; SMN2KDM4E
SCHEMBL5465624 0.76 ABL1 (0.42) ALDH1A1TSHRSMN1; SMN2KDM4EMAPT
SCHEMBL18547962 0.76 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2CASP1KDM4EMAPT
SCHEMBL3181993 0.76 ALDH1A1 (0.48) ALDH1A1TSHRSMN1; SMN2CASP1KDM4E
SCHEMBL2553639 0.76 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2KDM4EPOLBALOX15
SCHEMBL730792 0.74 ALB (0.41) ALDH1A1SMN1; SMN2KDM4ELMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11160278-B2 Use of active substances for controlling virus infection in plants BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2021-11-02 US claimed
CN-108463108-B Use of active substances for controlling plant virus infections 拜耳作物科学股份公司 2021-02-19 CN claimed
EP-3402334-B1 USE OF ACTIVE SUBSTANCES FOR CONTROLLING VIRUS INFECTION IN PLANTS BAYER CROPSCIENCE AG (DE) 2020-05-27 EP claimed
CN-106038558-B Compounds and methods for modulating integrin CD11b/CD18 GB006公司 2020-01-10 CN claimed
US-20190335752-A1 USE OF ACTIVE SUBSTANCES FOR CONTROLLING VIRUS INFECTION IN PLANTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-11-07 US claimed
EP-3402334-A1 USE OF ACTIVE SUBSTANCES FOR CONTROLLING VIRUS INFECTION IN PLANTS Bayer CropScience Aktiengesellschaft (DE) 2018-11-21 EP claimed
CN-108463108-A Active material is used to prevent the purposes of plant virus infection 拜耳作物科学股份公司 2018-08-28 CN claimed
WO-2017121811-A1 USE OF ACTIVE SUBSTANCES FOR CONTROLLING VIRUS INFECTION IN PLANTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-07-20 WO claimed
US-9682940-B2 Indazole derivatives useful as CB-1 inverse agonists JANSSEN PHARMACEUTICA NV (BE) 2017-06-20 US claimed
WO-2017034872-A1 INDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS JANSSEN PHARMACEUTICA NV (BE) 2017-03-02 WO claimed
US-20170057925-A1 INDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS JANSSEN PHARMACEUTICA NV (BE) 2017-03-02 US claimed
CN-106038558-A Compounds and methods for regulating integrin CD11B/CD18 阿德黑雷制药公司 2016-10-26 CN claimed
CN-103189500-B Compounds and methods for modulating integrin CD11b/CD18 阿德黑雷制药公司 2016-06-15 CN claimed
US-9023876-B2 Compounds and methods for regulating integrins ADHAERE PHARMACEUTICALS, INC. (US) 2015-05-05 US claimed
US-20070276011-A1 Plasminogen Activator Inhibitor-1 Inhibitor INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2007-11-29 US claimed
EP-1666469-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR Institute of Medicinal Molecular Design, Inc. (JP) 2006-06-07 EP claimed
CN-1753871-A Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines CIBA SC HOLDING AG (CH) 2006-03-29 CN claimed
CN-111433290-B Azo compound or salt thereof, and polarizing element, polarizing plate and display device each comprising the same 日本化药株式会社 2022-06-14 CN disclosed
US-4935466-A Modified block copolymers and process for the preparation thereof SHELL OIL COMPANY (US) 1990-06-19 US disclosed
EP-0368395-A1 Lubricating oil composition SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1990-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11160278-B2 Use of active substances for controlling virus infection in plants GUSB, AS3MT, CAT ALDH1A1 1765/4885TP53 2216/4885TSHR 4513/4885
US-20070276011-A1 Plasminogen Activator Inhibitor-1 Inhibitor SERPINE1, SERPINC1, SERPINB1 ALDH1A1 1861/4885TP53 3114/4885TSHR 2228/4885
US-20190335752-A1 USE OF ACTIVE SUBSTANCES FOR CONTROLLING VIRUS INFECTION IN PLANTS GUSB, AS3MT, CAT ALDH1A1 1765/4885TP53 2216/4885TSHR 4513/4885
US-20170057925-A1 INDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS CNR1, GPR119, CNR2 ALDH1A1 689/4885TP53 4463/4885TSHR 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.